|
Kronos Bio, Inc. (KRON) Avaliação DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Kronos Bio, Inc. (KRON) Bundle
Seja você um investidor ou analista, esta calculadora DCF (KRON) é o seu recurso preferido para uma avaliação precisa. Pré -carregado com dados reais da Kronos Bio, Inc., você pode ajustar as previsões e observar instantaneamente os efeitos.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | 6.3 | 6.3 | 6.3 | 6.3 | 6.3 | 6.3 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -15.5 | -79.7 | -147.0 | -128.7 | -119.7 | 3.8 | 3.8 | 3.8 | 3.8 | 3.8 |
| EBITDA, % | 100 | 100 | 100 | 100 | -1903.53 | 60 | 60 | 60 | 60 | 60 |
| Depreciation | .6 | 4.9 | 4.1 | 4.5 | 2.1 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 |
| Depreciation, % | 100 | 100 | 100 | 100 | 33.97 | 86.79 | 86.79 | 86.79 | 86.79 | 86.79 |
| EBIT | -16.1 | -84.6 | -151.1 | -133.2 | -121.8 | 3.8 | 3.8 | 3.8 | 3.8 | 3.8 |
| EBIT, % | 100 | 100 | 100 | 100 | -1937.5 | 60 | 60 | 60 | 60 | 60 |
| Total Cash | 92.2 | 462.1 | 339.5 | 247.9 | 173.0 | 6.3 | 6.3 | 6.3 | 6.3 | 6.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .6 | .8 | .6 | .0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 0 | 80 | 80 | 80 | 80 | 80 |
| Inventories | -.2 | -49.6 | -.8 | -10.3 | .0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 |
| Inventories, % | 100 | 100 | 100 | 100 | 0 | 80 | 80 | 80 | 80 | 80 |
| Accounts Payable | 1.5 | 4.6 | 1.0 | 5.0 | .9 | 5.2 | 5.2 | 5.2 | 5.2 | 5.2 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 14.04 | 82.81 | 82.81 | 82.81 | 82.81 | 82.81 |
| Capital Expenditure | -2.9 | -9.6 | -4.3 | -.6 | -.7 | -.1 | -.1 | -.1 | -.1 | -.1 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | -10.8 | -2.16 | -2.16 | -2.16 | -2.16 | -2.16 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -15.4 | -61.3 | -149.1 | -129.3 | -121.8 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -16.1 | -14.1 | -201.8 | -111.6 | -134.3 | 3.1 | 8.8 | 8.8 | 8.8 | 8.8 |
| WACC, % | 9.68 | 9.36 | 9.72 | 9.69 | 9.73 | 9.64 | 9.64 | 9.64 | 9.64 | 9.64 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 28.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 9 | |||||||||
| Terminal Value | 118 | |||||||||
| Present Terminal Value | 74 | |||||||||
| Enterprise Value | 103 | |||||||||
| Net Debt | -36 | |||||||||
| Equity Value | 139 | |||||||||
| Diluted Shares Outstanding, MM | 58 | |||||||||
| Equity Value Per Share | 2.41 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Kronos Bio, Inc. (KRON) financial data pre-filled to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A sleek Excel model that adjusts to your valuation requirements.
- Built for Analysts and Investors: Perfect for assessing projections, validating strategies, and enhancing efficiency.
Key Features
- Comprehensive KRON Data: Pre-filled with Kronos Bio's historical performance metrics and future projections.
- Customizable Assumptions: Modify growth rates, profit margins, discount rates, tax implications, and capital investments.
- Interactive Valuation Framework: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Analysis: Develop multiple forecasting scenarios to explore various valuation possibilities.
- Intuitive User Interface: Clean, organized, and tailored for both experienced professionals and newcomers.
How It Works
- Step 1: Download the prebuilt Excel template featuring Kronos Bio, Inc.'s (KRON) data.
- Step 2: Navigate through the pre-filled sheets to grasp the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see recalculated results, including Kronos Bio, Inc.'s (KRON) intrinsic value.
- Step 5: Make well-informed investment choices or create reports based on the outputs.
Why Choose This Calculator for Kronos Bio, Inc. (KRON)?
- User-Friendly Interface: Tailored for both novices and seasoned professionals.
- Customizable Variables: Adjust inputs effortlessly to suit your analytical needs.
- Real-Time Feedback: Monitor immediate changes to Kronos Bio’s valuation as you tweak inputs.
- Pre-Configured Data: Comes with Kronos Bio’s latest financial information for swift evaluations.
- Relied Upon by Experts: Employed by investors and analysts for making well-informed choices.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for portfolio assessment of Kronos Bio, Inc. (KRON).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver precise valuation insights to clients regarding Kronos Bio, Inc. (KRON).
- Students and Educators: Utilize real-time data to enhance learning and practice in financial modeling.
- Biotech Enthusiasts: Gain insights into the valuation processes of biotech firms like Kronos Bio, Inc. (KRON).
What the Template Contains
- Pre-Filled DCF Model: Kronos Bio, Inc.’s (KRON) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Kronos Bio, Inc.’s (KRON) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.